KSR-style obviousness analysis
Should Pharma Focus on New Chemical Entities to Avoid Patent Challenge?
January 20 by Andrea CharlesAs part of the new Pharma Leaders Today series, Philip C. Strassburger, V.P., Intellectual Property Counsel at Purdue Pharma, spoke to Andrea Charles from Pharma IQ, about what trends h...